Cited by 340Muscle Physiology and DisordersMuscle metabolism and nutritionNutrition and Health in Aging

Signalling pathways regulating muscle mass in ageing skeletal muscle. The role of the IGF1-Akt-mTOR-FoxO pathway

Open access
Sandri, M., Barberi, L., Bijlsma, A. Y., Blaauw, B., Dyar, K. A., Milan, G., Mammucari, C., Meskers, C. G. M. +15 more·2013·Biogerontology

Abstract

During ageing skeletal muscles undergo a process of structural and functional remodelling that leads to sarcopenia, a syndrome characterized by loss of muscle mass and force and a major cause of physical frailty. To determine the causes of sarcopenia and identify potential targets for interventions aimed at mitigating ageing-dependent muscle wasting, we focussed on the main signalling pathway known to control protein turnover in skeletal muscle, consisting of the insulin-like growth factor 1 (IGF1), the kinase Akt and its downstream effectors, the mammalian target of rapamycin (mTOR) and the transcription factor FoxO. Expression analyses at the transcript and protein level, carried out on well-characterized cohorts of young, old sedentary and old active individuals and on mice aged 200, 500 and 800 days, revealed only modest age-related differences in this pathway. Our findings suggest that during ageing there is no downregulation of IGF1/Akt pathway and that sarcopenia is not due to FoxO activation and upregulation of the proteolytic systems. A potentially interesting result was the increased phosphorylation of the ribosomal protein S6, indicative of increased activation of mTOR complex1 (mTORC1), in aged mice. This result may provide the rationale why rapamycin treatment and caloric restriction promote longevity, since both interventions blunt activation of mTORC1; however, this change was not statistically significant in humans. Finally, genetic perturbation of these pathways in old mice aimed at promoting muscle hypertrophy via Akt overexpression or preventing muscle loss through inactivation of the ubiquitin ligase atrogin1 were found to paradoxically cause muscle pathology and reduce lifespan, suggesting that drastic activation of the IGF1-Akt pathway may be counterproductive, and that sarcopenia is accelerated, not delayed, when protein degradation pathways are impaired.

Integrity signals

Registry

Crossref · 10.1007/s10522-013-9432-9

Cites

81 of 81 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

1 retracted

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Sandri, M., Barberi, L., Bijlsma, A. Y., Blaauw, B., Dyar, K. A., Milan, G., Mammucari, C., Meskers, C. G. M., Pallafacchina, G., Paoli, A., Pion, D., Roceri, M., Romanello, V., Serrano, A. L., Toniolo, L., Larsson, L., Maier, A. B., Muñoz-Cánoves, P., Musarò, A., Pende, M., Reggiani, C., Rizzuto, R., & Schiaffino, S.
Affiliations
  • Veneto Institute of Molecular Medicine (IT)
  • Italian Institute of Technology (IT)
  • Leiden University Medical Center (NL)
  • University of Padua (IT)
  • Inserm (FR)
  • Institució Catalana de Recerca i Estudis Avançats (ES)
  • Uppsala University (SE)
  • Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
Corresponding author
Schiaffino, S.
Venue
Biogerontology
Published
2013-05-19
Volume
14
Issue
3
Pages
303-323
ISSN
  • 1389-5729 (ISSN-L)
  • 1573-6768
OpenAlex
W2087071824
Cited by
340
References
81
Citations by year
2026: 16 · 2025: 12 · 2024: 23 · 2023: 20 · 2022: 32 · 2021: 34 · 2020: 24 · 2019: 25 · 2018: 24 · 2017: 39 · 2016: 28 · 2015: 22 · 2014: 30 · 2013: 10
FWCI
13.45
Type
journal article
Language
en
Open access
Locations
  • Biogerontology (publishedVersion)
  • PubMed (publishedVersion)
  • Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • HAL (submittedVersion)
  • Leiden Repository (Leiden University) (submittedVersion)
  • IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
  • Pure Amsterdam UMC (submittedVersion)
  • VU Research Portal (submittedVersion)
  • Padua Research Archive (University of Padova) (submittedVersion)
  • Zenodo (CERN European Organization for Nuclear Research) (submittedVersion, other-oa)
Funders
  • National Institute on Aging (P01AG014731, AG14731)
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR 45627, AR 47318, R01AR047318, R01AR045627)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Muscle metabolism and nutrition
  • Health Sciences › Medicine › Physiology › Nutrition and Health in Aging
Keywords
sarcopenia, skeletal muscle aging, mTORC1, S6 phosphorylation, protein turnover, muscle protein degradation, atrogin-1, rapamycin, caloric restriction, lifespan, muscle hypertrophy, frailty
MeSH terms
Tripartite Motif Proteins, Forkhead Box Protein O1, Autophagy-Related Protein 7, Adolescent, Adult, Aged, Aged, 80 and over, Aging, Animals, Female, Humans, Insulin-Like Growth Factor I, Male, Mice, Inbred C57BL, Mice, Inbred DBA, Mice, Transgenic, Microtubule-Associated Proteins, Muscle Proteins, Signal Transduction, Mice, Knockout, Muscle, Skeletal, Models, Animal, Ubiquitin-Protein Ligases, SKP Cullin F-Box Protein Ligases, Proto-Oncogene Proteins c-akt, Mice, Forkhead Transcription Factors, Young Adult, Sarcopenia, Serpin E2, TOR Serine-Threonine Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review